Company behind 2022 formula shortage to pay $384M over tainted formula
Abbott Laboratories agreed to pay $384M to settle federal and state allegations of knowingly selling potentially contaminated infant formula, stemming from unsanitary conditions at its Michigan and Arizona plants.
Original Source
Read the full article at Cleveland →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.